Answers are grounded in this paper and cite their sources.
The feasibility of obtaining standardized juvenile myositis assessments remotely remains uncertain. We evaluated the feasibility of telehealth disease activity assessments by comparing their completion rates with those of in-person assessments. This single-center retrospective cross-sectional study included 66 patients, each contributing one visit between April 2020 and August 2023: 28 telehealth and 38 in-person evaluations. Physicians directed caregiver-assisted muscle and functional assessments and video-based skin examinations. Childhood Myositis Assessment Scale (CMAS) assessments were completed in 24/28 telehealth visits (86%) and 37/38 in-person visits (97%; p = 0.15). Bilateral manual muscle testing (MMT-8) scores were recorded in 14/28 (50%) versus 37/38 (97%; p < 0.0001), with some remote examinations omitting required muscles. Cutaneous Dermatomyositis Disease Area and Severity Index completion was 50% versus 100% ( p < 0.0001); inadequate video quality was the principal limitation. Childhood Health Assessment Questionnaire completion was 54% versus 79% ( p = 0.035). Muscle testing and CMAS scores correlated in telehealth (rₛ=0.74) and in-person (rₛ=0.82) evaluations. Accuracy, reliability, agreement between modalities, and clinical safety were not evaluated. CMAS was the most consistently completed remote muscle or functional assessment. Telehealth assessments provided less complete information than in-person evaluations. Prospective paired studies are needed to validate remote measures and assess clinical safety and family perspectives.
No takes yet. Share an insight, caveat, or question.
Khanna et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: